Navigation Links
Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-Specific Peptides for Sexual Dysfunction
Date:5/2/2013

CRANBURY, N.J., May 2, 2013 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application Serial Number 12/952,238 (the '238 application).  The application includes composition of matter claims on a new class of melanocortin receptor- specific peptides for sexual dysfunction and other indications.

The '238 application is the first patent application to issue covering a novel family of melanocortin-4 receptor agonist peptides.  The melanocortin-4 receptor mediates sexual response, and agonists have been studied for treatment of both erectile dysfunction and female sexual dysfunction.  Palatin's bremelanotide product, a melanocortin-4 receptor agonist peptide drug administered using an autoinjector, has recently completed Phase 2 human studies for female sexual dysfunction, with pivotal Phase 3 clinical studies scheduled to start later this year.

The peptides in the '238 application demonstrated effects on sexual function in animal models.  Palatin is evaluating these peptides as potential follow-on or second generation products for treatment of sexual dysfunction.  The melanocortin-4 receptor also has potential utility in treatment of obesity, metabolic syndrome and other indications.

"As we move into Phase 3 with bremelanotide for female sexual dysfunction, we are pleased to have new peptides with improved profiles suitable for use as second generation products," stated Carl Spana , Ph.D., President and CEO of Palatin.

A Notice of Allowance is issued after the USPTO makes a determination that a patent can be granted from an application. The issued
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Palatin Technologies To Present At The 25th Annual ROTH Conference
2. Palatin Technologies, Inc. To Present At The Cowen & Company 33rd Annual Health Care Conference
3. Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2013 Results; Teleconference and Webcast to be held on February 14, 2013
4. Palatin Technologies, Inc. To Report Fiscal Year 2013 Second Quarter Results; Teleconference and Webcast to be held on February 14, 2013
5. Palatin Technologies, Inc. to Present at 15th Annual BIO CEO & Investor Conference
6. Palatin Technologies, Inc. to Present at the 24th Annual Piper Jaffray Healthcare Conference
7. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2013 Results; Teleconference and Webcast to be held on November 14, 2012
8. Palatin Technologies, Inc. To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
9. Palatin Technologies, Inc. To Report Fiscal Year 2013 First Quarter Results; Teleconference and Webcast to be held on November 14, 2012
10. Palatin Technologies Reports Positive Results for Phase 2B Bremelanotide Female Sexual Dysfunction Trial
11. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2015)...  A San Francisco company, Pembient, recently announced it ... horn: beer in China and ... response to the emerging industry, two leading rhino conservation ... synthetic rhino horn.  The International ... International (SRI) released a joint statement ...
(Date:6/26/2015)... ... June 26, 2015 , ... DNA Genotek, a ... OraSure Technologies, Inc. (Nasdaq: OSUR) today announced that it has awarded grants to ... Microbiome Grant Program. The company has awarded its OMNIgene®â€¢GUT fecal/stool collection ...
(Date:6/25/2015)... DUBLIN , June 25, 2015 ... Markets ( http://www.researchandmarkets.com/research/vxtfvv/2015_market ) has announced the ... Analysis of the Global Cancer Diagnostics ... CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, ... offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ...
(Date:6/25/2015)... 25, 2015  BioMed Realty Trust, Inc. (NYSE: ... ILMN ), a world leader in genomics focused on ... genome, has signed a 20-year lease for a 155,000 ... Cambridge, England . The project will ... highly skilled workforce in the dynamic research cluster anchored ...
Breaking Biology Technology:Rhino Experts Oppose Synthetic Rhino Horn as Solution to Poaching Crisis 2DNA Genotek Inc. Announces Recipients of Gut Microbiome Grant Program 2DNA Genotek Inc. Announces Recipients of Gut Microbiome Grant Program 3Analysis of the Global Cancer Diagnostics Industry 2015-2020: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains 2Analysis of the Global Cancer Diagnostics Industry 2015-2020: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains 3BioMed Realty And Illumina Announce New Build-To-Suit Laboratory Building In Cambridge's Growing Life Science Cluster 2BioMed Realty And Illumina Announce New Build-To-Suit Laboratory Building In Cambridge's Growing Life Science Cluster 3
... Next Clinical StudiesOMAHA, Neb. and HOUSTON, May 11 ... Power3 Medical Products, Inc. (OTC Bulletin Board: PWRM), ... and NuroPro(R) PD tests for Alzheimer,s and Parkinson,s ... meeting in Seattle, WA. The NuroPro tests help ...
... Inc. (Pink Sheets: NNLX) is pleased to announce the ... and target research and development efforts for products. ... vastly expanded scope of expertise in both medicine and ... of numerous NanoLogix patents, has resigned from the NanoLogix ...
... Panel DiscussionATLANTA, May 11 , WHAT: GeoVax Labs, ... publicly traded biopharmaceutical company developing human, ... Virus) and other ... the future and plans to expand preventative trials, currently in, ...
Cached Biology Technology:Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting 2Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting 3Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting 4Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting 5A Global View: NanoLogix Creates Science Advisory Board 2A Global View: NanoLogix Creates Science Advisory Board 3A Global View: NanoLogix Creates Science Advisory Board 4A Global View: NanoLogix Creates Science Advisory Board 5
(Date:6/25/2015)... PRINCETON, N.J. , June 25, 2015  TAKE ... awarded a patent by the United States Patent and ... Data Standardization". This process leverages TAKE Solutions, Clinical Accelerators ... by over 50% (when compared to standardization without the ... At the heart ...
(Date:6/24/2015)... June 22, 2015 ... addition of the "Huawei Ascend Mate 7 ... to their offering. Huawei,s technological choice ... opposite direction than Apple,s and Samsung,s one. The ... developed by Fingerprint Cards, a main actor in ...
(Date:6/23/2015)... 2015   Valencell, a leader in ... a recent study that illustrates its PerformTek biometric ... activity. In a study conducted at Valencell,s Biometric ... the Apple Watch against a chest strap – ... activity. The study demonstrated that Valencell,s biometric technology ...
Breaking Biology News(10 mins):TAKE Solutions Awarded Patent By USPTO 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... [Brown University] If you want to understand a novel, it ... up the plot from somewhere in the middle. The same goes ... sense of it is to look at it head to tail. ... University, DNA molecules have a convenient tendency to cooperate. The ...
... colleagues have shown that one of the mechanisms involved in hearing ... that isn,t interesting enough, the UI scientists advanced their knowledge of ... by making use of the fruit fly "love song." To ... to know that the auditory system of the fruit fly contains ...
... Parents of newborn babies are always creeping into the nursery ... Alternatively, they might let baby sleep in their room, hoping ... too late. In future, a romper suit with an integrated ... stops breathing. The cornerstone of the sensor system is a ...
Cached Biology News:DNA prefers to dive head first into nanopores 2DNA prefers to dive head first into nanopores 3UI researcher learns mechanism of hearing is similar to car battery 2Romper suit to protect against sudden infant death 2Romper suit to protect against sudden infant death 3
... Non-ionic Detergent Removal , , ... virtually no cross-reactivity with other proteins , ... , Economical new surface technology, not ... often interfere with protein analysis. SurfactAway offers ...
SDS-OutT SDS Precipitation Reagent...
... TRAC is a platform for fully automated ... It can easily be configured for applications ... molecular biology.TRAC allows closed loop screening, which ... hit list generating, cherry picking and follow ...
... Series of systems provide fast and reliable scalable automation ... development laboratories. Staccato systems are available in three base ... Series. ... All Staccato Application ...
Biology Products: